HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 358 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,984,644 | +11.2% | 51,730 | -1.1% | 0.03% | +12.0% |
| Q2 2023 | $5,381,112 | -5.8% | 52,320 | 0.0% | 0.02% | -16.7% |
| Q1 2023 | $5,710,205 | -1.2% | 52,320 | +3.0% | 0.03% | -11.8% |
| Q4 2022 | $5,777,967 | +94.8% | 50,773 | +6.0% | 0.03% | +78.9% |
| Q3 2022 | $2,966,000 | -22.4% | 47,920 | 0.0% | 0.02% | -20.8% |
| Q2 2022 | $3,822,000 | -19.8% | 47,920 | +5.8% | 0.02% | -7.7% |
| Q1 2022 | $4,765,000 | +4.8% | 45,295 | +7.4% | 0.03% | +13.0% |
| Q4 2021 | $4,546,000 | +1.1% | 42,183 | +2.8% | 0.02% | -8.0% |
| Q3 2021 | $4,496,000 | +9.0% | 41,041 | -6.9% | 0.02% | +4.2% |
| Q2 2021 | $4,126,000 | +15.0% | 44,061 | +13.0% | 0.02% | +4.3% |
| Q1 2021 | $3,589,000 | +27.5% | 38,990 | +1.3% | 0.02% | +21.1% |
| Q4 2020 | $2,816,000 | – | 38,490 | – | 0.02% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 548,715 | $59,130,000 | 25.86% |
| Paulson & Co. | 6,000,000 | $646,560,000 | 19.94% |
| Avoro Capital Advisors LLC | 9,295,000 | $1,001,629,000 | 17.05% |
| Asymmetry Capital Management, L.P. | 137,610 | $14,829,000 | 7.87% |
| 1492 Capital Management LLC | 119,995 | $12,931,000 | 6.37% |
| Eversept Partners, LP | 833,750 | $89,844,900 | 5.74% |
| HealthCor Management, L.P. | 832,270 | $89,685,000 | 4.88% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1,063,236 | $114,574,000 | 4.38% |
| PFM Health Sciences, LP | 1,091,840 | $117,657,000 | 4.01% |
| Ikarian Capital, LLC | 246,900 | $26,607,000 | 3.96% |